{"database": "lobbying", "table": "lobbying_activities", "rows": [[2632467, "de946648-f5e6-4365-9aa9-e80d3617ea6e", "Q2", "HORIZON GOVERNMENT AFFAIRS", 315592, "PHRMA", 2021, "second_quarter", "HCR", "340B, Medicare Part D, Medicare Part B Issues, Medicare non-interference, Medicare Part D Rebates, Importation of Drugs, Drug Pricing, Coronavirus Issues.", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2021-07-01T15:23:30.710000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2632467"], "units": {}, "query_ms": 120.52953604143113, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}